{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Elephantopus carolinianus", "Elephantopus scaber", "apoptosis", "cancer", "deoxyelephantopin", "inflammation", "isodeoxyelephantopin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28635648", "DateCompleted": {"Year": "2017", "Month": "08", "Day": "02"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "06", "Day": "21"}], "Language": ["eng"], "ELocationID": ["1013", "10.3390/molecules22061013"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "6", "PubDate": {"Year": "2017", "Month": "Jun", "Day": "21"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Deoxyelephantopin and Isodeoxyelephantopin as Potential Anticancer Agents with Effects on Multiple Signaling Pathways.", "Abstract": {"AbstractText": ["Cancer is the 2nd leading cause of death worldwide. The development of drugs to target only one specific signaling pathway has limited therapeutic success. Developing chemotherapeutics to target multiple signaling pathways has emerged as a new prototype for cancer treatment. Deoxyelephantopin (DET) and isodeoxyelephantopin (IDET) are sesquiterpene lactone components of \"<i>Elephantopus scaber and Elephantopus carolinianus</i>\", traditional Chinese medicinal herbs that have long been used as folk medicines to treat liver diseases, diabetes, diuresis, bronchitis, fever, diarrhea, dysentery, cancer, and inflammation. Recently, the anticancer activity of DET and IDET has been widely investigated. Here, our aim is to review the current status of DET and IDET, and discuss their anticancer activity with specific emphasis on molecular targets and mechanisms used by these compounds to trigger apoptosis pathways which may help to further design and conduct research to develop them as lead therapeutic drugs for cancer treatments. The literature has shown that DET and IDET induce apoptosis through multiple signaling pathways which are deregulated in cancer cells and suggested that by targeting multiple pathways simultaneously, these compounds could selectively kill cancer cells. This review suggests that DET and IDET hold promising anticancer activity but additional studies and clinical trials are needed to validate and understand their therapeutic effect to develop them into potent therapeutics for the treatment of cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China. tahir_nanotech@yahoo.com."}], "LastName": "Mehmood", "ForeName": "Tahir", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China. amara_khan2015@yahoo.com."}], "LastName": "Maryam", "ForeName": "Amara", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Advanced Materials Science, King Khalid University, Abha 61413, P.O. Box 9004, Saudi Arabia. hamedsa@hotmail.com."}, {"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, King Khalid University, Abha 61413, P.O. Box 9004, Saudi Arabia. hamedsa@hotmail.com."}], "LastName": "Ghramh", "ForeName": "Hamed A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China. khan_zoologist@ymail.com."}], "LastName": "Khan", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China. tonghuima@dlmedu.edu.cn."}], "LastName": "Ma", "ForeName": "Tonghui", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactones"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "deoxyelephantopin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Asteraceae"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Lactones"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects", "metabolism", "therapeutic use"], "DescriptorName": "Transcription Factors"}], "CoiStatement": "The authors declare that there is no conflict of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Khan M., Maryam A., Qazi J.I., Ma T. Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells. Int. J. Biol. Sci. 2015;11:1100\u20131112. doi: 10.7150/ijbs.11595.", "ArticleIdList": ["10.7150/ijbs.11595", "PMC4515820", "26221076"]}, {"Citation": "Begnini K.R., Moura de Leon P.M., Thurow H., Schultze E., Campos V.F., Martins Rodrigues F., Borsuk S., Dellagostin O.A., Savegnago L., Roesch-Ely M., et al. Brazilian Red Propolis Induces Apoptosis-Like Cell Death and Decreases Migration Potential in Bladder Cancer Cells. Evid. Based Complement. Altern. Med. 2014;2014:639856. doi: 10.1155/2014/639856.", "ArticleIdList": ["10.1155/2014/639856", "PMC4235187", "25530785"]}, {"Citation": "Millimouno F.M., Dong J., Yang L., Li J., Li X. Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature. Cancer Prev. Res. 2014;7:1081. doi: 10.1158/1940-6207.CAPR-14-0136.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0136", "25161295"]}, {"Citation": "Khan M., Maryam A., Zhang H., Mehmood T., Ma T. Killing cancer with platycodin D through multiple mechanisms. J. Cell. Mol. Med. 2016;20:389\u2013402. doi: 10.1111/jcmm.12749.", "ArticleIdList": ["10.1111/jcmm.12749", "PMC4759477", "26648178"]}, {"Citation": "Cragg G.M., Newman D.J. NATURAL PRODUCTS: A CONTINUING SOURCE OF NOVEL DRUG LEADS. Biochim. Biophys. Acta. 2013;1830:3670\u20133695. doi: 10.1016/j.bbagen.2013.02.008.", "ArticleIdList": ["10.1016/j.bbagen.2013.02.008", "PMC3672862", "23428572"]}, {"Citation": "Rasul A., Millimouno F.M., Ali Eltayb W., Ali M., Li J., Li X. Pinocembrin: A Novel Natural Compound with Versatile Pharmacological and Biological Activities. BioMed. Res. Int. 2013;2013:379850. doi: 10.1155/2013/379850.", "ArticleIdList": ["10.1155/2013/379850", "PMC3747598", "23984355"]}, {"Citation": "Prakash O., Kumar A., Kumar P., Ajeet A. Anticancer Potential of Plants and Natural Products: A Review. Am. J. Pharmacol. Sci. 2013;6:104\u2013115. doi: 10.12691/ajps-1-6-1.", "ArticleIdList": ["10.12691/ajps-1-6-1"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;1:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Newman D.J., Cragg G.M., Snader K.M. Natural Products as Sources of New Drugs over the Period 1981\u20132002. J. Nat. Prod. 2003;7:1022\u20131037. doi: 10.1021/np030096l.", "ArticleIdList": ["10.1021/np030096l", "12880330"]}, {"Citation": "Pratheeshkumar P., Sreekala C., Zhang Z., Budhraja A., Ding S., Son Y.O., Wang X., Hitron A., Hyun-Jung K., Wang L., et al. Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets. Anti-Cancer Agents Med. Chem. 2012;10:1159\u20131184. doi: 10.2174/187152012803833035.", "ArticleIdList": ["10.2174/187152012803833035", "PMC4983770", "22583402"]}, {"Citation": "Amin A.R., Kucuk O., Khuri F.R., Shin D.M. Perspectives for cancer prevention with natural compounds. J. Clin. Oncol. 2009;16:2712\u20132725. doi: 10.1200/JCO.2008.20.6235.", "ArticleIdList": ["10.1200/JCO.2008.20.6235", "PMC2690394", "19414669"]}, {"Citation": "Rasul A., Khan M., Ali M., Li J., Li X. Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone. Sci. World J. 2013;2013:248532. doi: 10.1155/2013/248532.", "ArticleIdList": ["10.1155/2013/248532", "PMC3826378", "24288468"]}, {"Citation": "Ogbourne S.M., Parsons P.G. The value of nature's natural product library for the discovery of New Chemical Entities: The discovery of ingenol mebutate. Fitoterapia. 2014;98:36\u201344. doi: 10.1016/j.fitote.2014.07.002.", "ArticleIdList": ["10.1016/j.fitote.2014.07.002", "25016953"]}, {"Citation": "Harvey A.L. Natural products as a screening resource. Curr. Opin. Chem. Biol. 2007;5:480\u2013484. doi: 10.1016/j.cbpa.2007.08.012.", "ArticleIdList": ["10.1016/j.cbpa.2007.08.012", "17884696"]}, {"Citation": "Harvey A.L. Natural products in drug discovery. Drug Discov. Today. 2008;13:894\u2013901. doi: 10.1016/j.drudis.2008.07.004.", "ArticleIdList": ["10.1016/j.drudis.2008.07.004", "18691670"]}, {"Citation": "Divya G.S., Mansoor K.P., Rasheed S.P., Kumar A. PPAR gamma agonist: An effect strategy for cancer treatment. JPSI. 2013;5 doi: 10.7897/2277-4572.02575.", "ArticleIdList": ["10.7897/2277-4572.02575"]}, {"Citation": "Zhang D., Haruna M., McPhail A.T., Lee K.-H. Cytotoxic germacranolides of Elephantopus carolinianus and the structure and stereochemistry of isodeoxyelephantopin. Phytochemistry. 1986;4:899\u2013904. doi: 10.1016/0031-9422(86)80023-1.", "ArticleIdList": ["10.1016/0031-9422(86)80023-1"]}, {"Citation": "Xu G., Liang Q., Gong Z., Yu W., He S., Xi L. Antitumor activities of the four sesquiterpene lactones from Elephantopus scaber L. Exp. Oncol. 2006;2:106\u2013109.", "ArticleIdList": ["16837899"]}, {"Citation": "Zahari Z., Jani N.A., Amanah A., Latif M.N.A., Majid M.I.A., Adenan M.I. Bioassay-guided isolation of a sesquiterpene lactone of deoxyelephantopin from Elephantopus scaber Linn. active on Trypanosome brucei rhodesience. Phytomedicine. 2014;3:282\u2013285. doi: 10.1016/j.phymed.2013.09.011.", "ArticleIdList": ["10.1016/j.phymed.2013.09.011", "24269185"]}, {"Citation": "Wu T., Cui H., Cheng B., Fang S., Xu J., Gu Q. Chemical constituents from the roots of Elephantopus scaber L. Biochem. Syst. Ecol. 2014;54:65\u201367. doi: 10.1016/j.bse.2013.12.012.", "ArticleIdList": ["10.1016/j.bse.2013.12.012"]}, {"Citation": "Koe X.F., Lim E.L., Seah T.C., Amanah A., Wahab H.A., Adenan M.I., Sulaiman S.F., Tan M.L. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L. Food. Chem. Toxicol. 2013;60:98\u2013108. doi: 10.1016/j.fct.2013.07.030.", "ArticleIdList": ["10.1016/j.fct.2013.07.030", "23876819"]}, {"Citation": "Kabeer F.A., Sreedevi G.B., Nair M.S., Rajalekshmi D.S., Gopalakrishnan L.P., Prathapan R. Isodeoxyelephantopin from Elephantopus scaber (Didancao) induces cell cycle arrest and caspase-3-mediated apoptosis in breast carcinoma T47D cells and lung carcinoma A549 cells. Chin. Med. 2014;9:14. doi: 10.1186/1749-8546-9-14.", "ArticleIdList": ["10.1186/1749-8546-9-14", "PMC4003511", "24742378"]}, {"Citation": "Kabeer F.A., Prathapan R. phytopharmacological prolife of Elephantopus scabcer. Pharmacologia. 2014;8:272\u2013285."}, {"Citation": "Beeran A.A., Maliyakkal N., Rao C.M., Udupa N. The enriched fraction of Elephantopus scaber Triggers apoptosis and inhibits multi-drug resistance transporters in human epithelial cancer cells. Pharmacogn. Mag. 2015;42:257\u2013268.", "ArticleIdList": ["PMC4378122", "25829763"]}, {"Citation": "Ahmad A., Alkarkhi A.F.M., Hena S., Khim L.H. Extraction, Separation and Identification of Chemical Ingredients of Elephantopus Scaber L. Using Factorial Design of Experiment. Int. J. Chem. 2009;1:36\u201349. doi: 10.5539/ijc.v1n1p36.", "ArticleIdList": ["10.5539/ijc.v1n1p36"]}, {"Citation": "Ho W.Y., Yeap S.K., Ho C.L., Rahim R.A., Alitheen N.B. Hepatoprotective Activity of Elephantopus scaber on Alcohol-Induced Liver Damage in Mice. Evid. Based Complement. Altern. Med. 2012;2012:417953. doi: 10.1155/2012/417953.", "ArticleIdList": ["10.1155/2012/417953", "PMC3437691", "22973401"]}, {"Citation": "Hammer M.L.A., Johns E.A. Tapping an Amaz\u00f4nian plethora: Four medicinal plants of Maraj\u00f3 Island, Par\u00e1 (Brazil) J. Ethnopharmacol. 1993;1:53\u201375. doi: 10.1016/0378-8741(93)90089-N.", "ArticleIdList": ["10.1016/0378-8741(93)90089-N", "8246531"]}, {"Citation": "Ho1 W.N., Ky H., Yeap S.K., Rahim R.A., Omar A.R., Ho C.L., Alitheen N.B. Traditional practice, bioactivities and commercialization potential of Elephantopus scaber Linn. J. Med. Plants Res. 2009;13:1212\u20131221."}, {"Citation": "Lin C.-C., Tsai C.-C., Yen M.-H. The evaluation of hepatoprotective effects of Taiwan folk medicine \u2018Teng-Khia-U\u2019. J. Ethnopharmacol. 1995;2:113\u2013123. doi: 10.1016/0378-8741(94)01198-9.", "ArticleIdList": ["10.1016/0378-8741(94)01198-9", "7776660"]}, {"Citation": "Hung H.-F., Hou C.-W., Chen Y.-L., Lin C.-C., Fu H.-W., Wang J.-S., Jeng K.-C. Elephantopus Scaber Inhibits Lipopolysaccharide-Induced Liver Injury by Suppression of Signaling Pathways in Rats. Am. J. Chin. Med. 2011;4:705\u2013717. doi: 10.1142/S0192415X11009147.", "ArticleIdList": ["10.1142/S0192415X11009147", "21721151"]}, {"Citation": "Kabiru A. Elephantopus Species: Traditional Uses, Pharmacological Actions and Chemical Composition. Adv. Life Sci. Technol. 2013;15:6\u201313."}, {"Citation": "Yan G.-R., Tan Z., Wang Y., Xu M.-L., Yu G., Li Y., He Q.-Y. Quantitative proteomics characterization on the antitumor effects of isodeoxyelephantopin against nasopharyngeal carcinoma. Proteomics. 2013;13:3222\u20133232. doi: 10.1002/pmic.201300152.", "ArticleIdList": ["10.1002/pmic.201300152", "23970500"]}, {"Citation": "Su M., Chung H.Y., Li Y. Deoxyelephantopin from Elephantopus scaber L. induces cell-cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells. Biochem. Biophys. Res. Commun. 2011;2:342\u2013347.", "ArticleIdList": ["21741953"]}, {"Citation": "Farha A.K., Dhanya S.R., Mangalam S.N., Geetha B.S., Latha P.G., Remani P. Deoxyelephantopin impairs growth of cervical carcinoma SiHa cells and induces apoptosis by targeting multiple molecular signaling pathways. Cell Biol. Toxicol. 2014;6:331\u2013343. doi: 10.1007/s10565-014-9288-z.", "ArticleIdList": ["10.1007/s10565-014-9288-z", "25260383"]}, {"Citation": "Huang C.-C., Lo C.-P., Chiu C.-Y., Shyur L.-F., Huang C.-C., Lo C.-P., Chiu C.-Y., Shyur L.-F. Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice. Br. J. Pharmacol. 2010;4:856\u2013871. doi: 10.1111/j.1476-5381.2009.00581.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00581.x", "PMC2829211", "20105176"]}, {"Citation": "Chan K.C., Chan G., Awang K., Kadir H.A. Deoxyelephantopin from Elephantopus scaber Inhibits HCT116 Human Colorectal Carcinoma Cell Growth through Apoptosis and Cell Cycle Arrest. Molecules. 2016;3:921\u2013937. doi: 10.3390/molecules21030385.", "ArticleIdList": ["10.3390/molecules21030385", "PMC6274388", "27007366"]}, {"Citation": "Chan C.K., Supriady H., Goh B.H., Kadir H.A. Elephantopus scaber induces apoptosis through ROS-dependent mitochondrial signaling pathway in HCT116 human colorectal carcinoma cells. J. Ethnopharmacol. 2015;168:291\u2013304. doi: 10.1016/j.jep.2015.03.072.", "ArticleIdList": ["10.1016/j.jep.2015.03.072", "25861953"]}, {"Citation": "Mehmood T., Maryam A., Zhang H., Li Y., Khan M., Ma T. Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-\u03baB inhibition and mitochondrial dysfunction. BioFactors. 2017;43:63\u201372. doi: 10.1002/biof.1324.", "ArticleIdList": ["10.1002/biof.1324", "27628030"]}, {"Citation": "Ichikawa H., Nair M.S., Takada Y., Sheeja D.B.A., Kumar M.A.S., Oommen O.V., Aggarwal B.B. Isodeoxyelephantopin, a Novel Sesquiterpene Lactone, Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis through Suppression of Nuclear Factor-\u03baB (NF-\u03baB) Activation and NF-\u03baB-Regulated Gene Expression. Clin. Cancer Res. 2006;19:5910\u20135918. doi: 10.1158/1078-0432.CCR-06-0916.", "ArticleIdList": ["10.1158/1078-0432.CCR-06-0916", "17021000"]}, {"Citation": "Kabeer F.A., Sreedevi G.B., Nair M.S., Rajalekshmi D.S., Gopalakrishnan L.P., Kunjuraman S., Prathapan R. Antineoplastic effects of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber, on lung adenocarcinoma (A549) cells. J. Integr. Med. 2013;4:269\u2013277. doi: 10.3736/jintegrmed2013040.", "ArticleIdList": ["10.3736/jintegrmed2013040", "23867245"]}, {"Citation": "Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics. Br. J. Cancer. 1972;4:239\u2013257. doi: 10.1038/bjc.1972.33.", "ArticleIdList": ["10.1038/bjc.1972.33", "PMC2008650", "4561027"]}, {"Citation": "Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009;1:3\u201311. doi: 10.1038/cdd.2008.150.", "ArticleIdList": ["10.1038/cdd.2008.150", "PMC2744427", "18846107"]}, {"Citation": "Panda A.K., Chakraborty D., Sarkar I., Khan T., Sa G. New insights into therapeutic activity and anticancer properties of curcumin. J. Exp. Pharmacol. 2017;9:31\u201345. doi: 10.2147/JEP.S70568.", "ArticleIdList": ["10.2147/JEP.S70568", "PMC5386596", "28435333"]}, {"Citation": "Amaral L., Spengler G., Molnar J. Identification of Important Compounds Isolated from Natural Sources that Have Activity against Multidrug-resistant Cancer Cell Lines: Effects on Proliferation, Apoptotic Mechanism and the Efflux Pump Responsible for Multi-resistance Phenotype. Anticancer Res. 2016;11:5665\u20135672. doi: 10.21873/anticanres.11149.", "ArticleIdList": ["10.21873/anticanres.11149", "27793887"]}, {"Citation": "Khan M., Rasul A., Yi F., Zhong L., Ma T. Jaceosidin Induces P53-Dependent G2/M Phase Arrest in U87 Glioblastoma Cells. Asian Pac. J. Cancer Prev. 2011;12:3235\u20133238.", "ArticleIdList": ["22471459"]}, {"Citation": "Gire V., Duli\u0107 V. Senescence from G2 arrest, revisited. Cell Cycle. 2015;3:297\u2013304. doi: 10.1080/15384101.2014.1000134.", "ArticleIdList": ["10.1080/15384101.2014.1000134", "PMC4353294", "25564883"]}, {"Citation": "Dutto I., Tillhon M., Cazzalini O., Stivala L.A., Prosperi E. Biology of the cell cycle inhibitor p21CDKN1A: Molecular mechanisms and relevance in chemical toxicology. Arch. Toxicol. 2015;2:155\u2013178. doi: 10.1007/s00204-014-1430-4.", "ArticleIdList": ["10.1007/s00204-014-1430-4", "25514883"]}, {"Citation": "Ohkoshi S., Yano M., Matsuda Y. Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy. World J. Gastroenterol. 2015;42:12150\u201312156. doi: 10.3748/wjg.v21.i42.12150.", "ArticleIdList": ["10.3748/wjg.v21.i42.12150", "PMC4641132", "26576099"]}, {"Citation": "Zou G., Gao Z., Wang J., Zhang Y., Ding H., Huang J., Chen L., Guo Y., Jiang H., Shen X. Deoxyelephantopin inhibits cancer cell proliferation and functions as a selective partial agonist against PPAR\u03b3. Biochem. Pharmacol. 2008;6:1381\u20131392. doi: 10.1016/j.bcp.2007.11.021.", "ArticleIdList": ["10.1016/j.bcp.2007.11.021", "18164690"]}, {"Citation": "Ferreira C.G., Epping M., Kruyt F.A.E., Giaccone G. Aopotosis. Clin. Cancer Res. 2002;7:2024.", "ArticleIdList": ["12114400"]}, {"Citation": "Siegmund D., Lang I., Wajant H. Cell death-independent activities of the death receptors CD95, TRAILR1, and TRAILR2. FEBS J. 2016;284:1131\u20131159. doi: 10.1111/febs.13968.", "ArticleIdList": ["10.1111/febs.13968", "27865080"]}, {"Citation": "Chen W., Hou J., Yin Y., Jang J., Zheng Z., Fan H., Zou G. \u03b1-Bisabolol induces dose- and time-dependent apoptosis in HepG2 cells via a Fas- and mitochondrial-related pathway, involves p53 and NF\u03baB. Biochem. Pharmacol. 2010;2:247\u2013254. doi: 10.1016/j.bcp.2010.03.021.", "ArticleIdList": ["10.1016/j.bcp.2010.03.021", "20346922"]}, {"Citation": "Yin Y., Chen W., Tang C., Ding H., Jang J., Weng M., Cai Y., Zou G. NF-\u03baB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G2/M cell cycle arrest. Food Chem. Toxicol. 2011;12:3046\u20133054. doi: 10.1016/j.fct.2011.10.001.", "ArticleIdList": ["10.1016/j.fct.2011.10.001", "22005259"]}, {"Citation": "Tower J. Programmed cell death in aging. Ageing Res. Rev. 2015;23:90\u2013100. doi: 10.1016/j.arr.2015.04.002.", "ArticleIdList": ["10.1016/j.arr.2015.04.002", "PMC4480161", "25862945"]}, {"Citation": "Hikita H., Kodama T., Tanaka S., Saito Y., Nozaki Y., Nakabori T., Shimizu S., Hayashi Y., Li W., Shigekawa M., et al. Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis. Cancer Prev. Res. 2015;8:693. doi: 10.1158/1940-6207.CAPR-15-0022-T.", "ArticleIdList": ["10.1158/1940-6207.CAPR-15-0022-T", "26038117"]}, {"Citation": "Nakagawa-Goto K., Chen J.-Y., Cheng Y.-T., Lee W.-L., Takeya M., Saito Y., Lee K.-H., Shyur L.-F. Novel sesquiterpene lactone analogues as potent anti-breast cancer agents. Mol. Oncol. 2016;6:921\u2013937. doi: 10.1016/j.molonc.2016.03.002.", "ArticleIdList": ["10.1016/j.molonc.2016.03.002", "PMC5152578", "27055598"]}, {"Citation": "Ivanova D., Zhelev Z., Aoki I., Bakalova R., Higashi T. Overproduction of reactive oxygen species-obligatory or not for induction of apoptosis by anticancer drugs. Chin. J. Cancer Res. 2016;4:383\u2013396. doi: 10.21147/j.issn.1000-9604.2016.04.01.", "ArticleIdList": ["10.21147/j.issn.1000-9604.2016.04.01", "PMC5018533", "27647966"]}, {"Citation": "Redza-Dutordoir M., Averill-Bates D.A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim. Biophys. Acta. 2016;12:2977\u20132992. doi: 10.1016/j.bbamcr.2016.09.012.", "ArticleIdList": ["10.1016/j.bbamcr.2016.09.012", "27646922"]}, {"Citation": "Singh V., Ram M., Kumar R., Prasad R., Roy B.K., Singh K.K. Phosphorylation: Implications in Cancer. Protein. J. 2017;36:1\u20136. doi: 10.1007/s10930-017-9696-z.", "ArticleIdList": ["10.1007/s10930-017-9696-z", "28108801"]}, {"Citation": "Liu M., Zhao G., Cao S., Zhang Y., Li X., Lin X. Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine. Front. Pharmacol. 2017;7:523. doi: 10.3389/fphar.2016.00523.", "ArticleIdList": ["10.3389/fphar.2016.00523", "PMC5220067", "28119606"]}, {"Citation": "Huang C.-C., Lin K.-J., Cheng Y.-W., Hsu C.-A., Yang S.-S., Shyur L.-F. Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis. J. Nutr. Biochem. 2013;3:516\u2013530. doi: 10.1016/j.jnutbio.2012.01.013.", "ArticleIdList": ["10.1016/j.jnutbio.2012.01.013", "22748804"]}, {"Citation": "Polychronidou G., Karavasilis V., Pollack S.M., Huang P.H., Lee A., Jones R.L. Novel therapeutic approaches in chondrosarcoma. Future Oncol. 2017;13:637\u2013648. doi: 10.2217/fon-2016-0226.", "ArticleIdList": ["10.2217/fon-2016-0226", "28133974"]}, {"Citation": "Tran P., Nguyen C., Klempner S.J. Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes? Int. Neurourol. 2016;20:S131\u2013S140. doi: 10.5213/inj.1632740.370.", "ArticleIdList": ["10.5213/inj.1632740.370", "PMC5169087", "27915478"]}, {"Citation": "Guerrero-Zotano A., Mayer I.A., Arteaga C.L. PI3K/AKT/mTOR: Role in breast cancer progression, drug resistance, and treatment. Cancer Metastasis Rev. 2016;4:515\u2013524. doi: 10.1007/s10555-016-9637-x.", "ArticleIdList": ["10.1007/s10555-016-9637-x", "27896521"]}, {"Citation": "Zhang W., Ma T., Li S., Yang Y., Guo J., Yu W., Kong L. Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules. Eur. J. Med. Chem. 2017;125:538\u2013550. doi: 10.1016/j.ejmech.2016.09.068.", "ArticleIdList": ["10.1016/j.ejmech.2016.09.068", "27718470"]}, {"Citation": "Nam S., Wen W., Schroeder A., Herrmann A., Yu H., Cheng X., Merz K.-H., Eisenbrand G., Li H., Yuan Y.-C., et al. Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells. Mol. Oncol. 2013;3:369\u2013378. doi: 10.1016/j.molonc.2012.10.013.", "ArticleIdList": ["10.1016/j.molonc.2012.10.013", "PMC3968804", "23206899"]}, {"Citation": "Yang S.-T., Yen C.-J., Lai C.-H., Lin Y.-J., Chang K.-C., Lee J.-C., Liu Y.-W., Chang-Liao P.-Y., Hsu L.-S., Chang W.-C., et al. SUMOylated CPAP is required for IKK-mediated NF-\u03baB activation and enhances HBx-induced NF-\u03baB signaling in HCC. J. Hepatol. 2013;6:1157\u20131164. doi: 10.1016/j.jhep.2013.01.025.", "ArticleIdList": ["10.1016/j.jhep.2013.01.025", "23369793"]}, {"Citation": "Siveen K.S., Sikka S., Surana R., Dai X., Zhang J., Kumar A.P., Tan B.K.H., Sethi G., Bishayee A. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochim. Biophys. Acta. 2014;2:136\u2013154. doi: 10.1016/j.bbcan.2013.12.005.", "ArticleIdList": ["10.1016/j.bbcan.2013.12.005", "24388873"]}, {"Citation": "Ramesh V., Selvarasu K., Pandian J., Myilsamy S., Shanmugasundaram C., Ganesan K. NF\u03baB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy. Cell. Oncol. 2016;6:523\u2013536. doi: 10.1007/s13402-016-0294-4.", "ArticleIdList": ["10.1007/s13402-016-0294-4", "27562587"]}, {"Citation": "Zhao L., Zhang Y. miR-342\u20133p affects hepatocellular carcinoma cell proliferation via regulating NF-\u03baB pathway. Biochem. Biophys. Res. Commun. 2015;3:370\u2013377. doi: 10.1016/j.bbrc.2014.12.119.", "ArticleIdList": ["10.1016/j.bbrc.2014.12.119", "25580008"]}, {"Citation": "Han S.-S., Yun H., Son D.-J., Tompkins V.S., Peng L., Chung S.-T., Kim J.-S., Park E.-S., Janz S. NF-\u03baB/STAT3/PI3K signaling crosstalk in iMyc(E\u03bc )B lymphoma. Mol. Cancer. 2010;9:97. doi: 10.1186/1476-4598-9-97.", "ArticleIdList": ["10.1186/1476-4598-9-97", "PMC2876994", "20433747"]}]}], "History": [{"Year": "2017", "Month": "5", "Day": "17"}, {"Year": "2017", "Month": "6", "Day": "8"}, {"Year": "2017", "Month": "6", "Day": "15"}, {"Year": "2017", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["28635648", "PMC6152668", "10.3390/molecules22061013", "molecules22061013"]}}]}